gavel-istock-508411976_andreypopov
AndreyPopov / iStockphoto.com
1 November 2017Big Pharma

Eli Lilly defeated as Cialis patent found obvious on appeal

The English Court of Appeal has ruled that patent claims protecting blockbuster drug Cialis (tadalafil) are invalid as obvious, handing victory to Actavis, Teva and Mylan.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 November 2017   Eli Lilly appears to be mulling whether to oppose a trademark registered by Bristol-Myers Squibb at the US Patent and Trademark Office.
Americas
10 April 2018   Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.
Big Pharma
27 March 2019   The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More on this story

Americas
21 November 2017   Eli Lilly appears to be mulling whether to oppose a trademark registered by Bristol-Myers Squibb at the US Patent and Trademark Office.
Americas
10 April 2018   Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.
Big Pharma
27 March 2019   The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More on this story

Americas
21 November 2017   Eli Lilly appears to be mulling whether to oppose a trademark registered by Bristol-Myers Squibb at the US Patent and Trademark Office.
Americas
10 April 2018   Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis.
Big Pharma
27 March 2019   The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.